The highly-anticipated and positive results from the IN-TIME study of home monitoring technology were recently presented in a hotline session at this year’s European Society of Cardiology (ESC) congress by coordinating investigator Professor Gerhard Hindricks MD, from the Heart Centre, University of Leipzig, Germany.
Shaken by two medical implant scandals, France is scrambling to rebuild confidence in its system of medical products and medication surveillance, John Brosky reports
Artificial hearts, originally designed to bridge the time on the waiting list for a heart transplant, in recent years have increasingly become an independent treatment option for patients with chronic heart failure (HF). Interview: Bettina Döbereiner
Cardiology is playing an increasingly important role in today’s healthcare environment and, as a direct result, cardiologists are facing new challenges almost every day. Addressing the need of improving clinician confidence and diagnostic accuracy, Toshiba Medical Systems Europe presented two symposia on the first day of the European Congress of Cardiology, to be held in Munich, Germany, 25-28…
The European medical technology industry association Eucomed notes with great concern recent press reports that the French firm Poly Implant Prothèse (PIP) may have violated the regulations by using unapproved industrial-grade silicone in some of its implantable products and by allegedly falsifying or withholding documents.
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.